Penicillin pharmacodynamics in four experimental pneumococcal infection models
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Erlendsdottir, HKnudsen, JD
Odenholt, I
Cars, O
Espersen, F
Frimodt-Møller, N
Fuursted, K
Kristinsson, KG
Gudmundsson, S
Issue Date
2001-04-01
Metadata
Show full item recordCitation
Antimicrob. Agents Chemother. 2001, 45(4):1078-85Abstract
Clinical and animal studies indicate that with optimal dosing, penicillin may still be effective against penicillin-nonsusceptible pneumococci (PNSP). The present study examined whether the same strains of penicillin-susceptible pneumococci (PSP) and PNSP differed in their pharmacodynamic responses to penicillin by using comparable penicillin dosing regimens in four animal models: peritonitis, pneumonia, and thigh infection in mice and tissue cage infection in rabbits. Two multidrug-resistant isolates of Streptococcus pneumoniae type 6B were used, one for which the penicillin MIC was 0.016 microg/ml and the other for which the penicillin MIC was 1.0 microg/ml. Two additional strains of PNSP were studied in the rabbit. The animals were treated with five different penicillin regimens resulting in different maximum concentrations of drugs in serum (C(max)s) and times that the concentrations were greater than the MIC (T(>MIC)s). The endpoints were bacterial viability counts after 6 h of treatment in the mice and 24 h of treatment in the rabbits. Similar pharmacodynamic effects were observed in all models. In the mouse models bactericidal activity depended on the T(>MIC) and to a lesser extent on the Cmax/MIC and the generation time but not on the area under the concentration-time curve (AUC)/MIC. Maximal bactericidal activities were similar for both PSP and PNSP, being the highest in the peritoneum and blood (approximately 6 log10 CFU/ml), followed by the thigh (approximately 3 log10 CFU/thigh), and being the lowest in the lung (approximately 1 log10 CFU/lung). In the rabbit model the maximal effect was approximately 6 log10 CFU/ml after 24 h. In the mouse models bactericidal activity became marked when T(>MIC) was > or =65% of the experimental time and C(max) was > or =15 times the MIC, and in the rabbit model bactericidal activity became marked when T(>MIC) was > or =35%, Cmax was > or =5 times the MIC, and the AUC at 24 h/MIC exceeded 25. By optimization of the Cmax/MIC ratio and T(>MIC), the MIC of penicillin for pneumococci can be used to guide therapy and maximize therapeutic efficacy in nonmeningeal infections caused by PNSP.Description
To access publisher full text version of this article. Please click on the hyperlink in Additional Links fieldAdditional Links
http://aac.asm.org/cgi/content/abstract/45/4/1078ae974a485f413a2113503eed53cd6c53
10.1128/AAC.45.4.1078-1085.2001
Scopus Count
Collections
Related articles
- The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
- Authors: Knudsen JD
- Issue date: 2000 Nov
- Selection of resistant Streptococcus pneumoniae during penicillin treatment in vitro and in three animal models.
- Authors: Knudsen JD, Odenholt I, Erlendsdottir H, Gottfredsson M, Cars O, Frimodt-Møller N, Espersen F, Kristinsson KG, Gudmundsson S
- Issue date: 2003 Aug
- In vivo pharmacodynamic activity of the glycopeptide dalbavancin.
- Authors: Andes D, Craig WA
- Issue date: 2007 May
- Pharmacodynamics of a new streptogramin, XRP 2868, in murine thigh and lung infection models.
- Authors: Andes D, Craig WA
- Issue date: 2006 Jan